News | October 14, 2008

Philips Tests New Decision Support Tool for Dementia Diagnosis

October 15, 2008 – Philips Research has concluded a usability and feasibility study of its decision support software tool for the automatic evaluation of dementia using PET (Positron Emission Tomography) image data.

The software has been evaluated in collaboration with the University Medical Center Hamburg-Eppendorf (Hamburg, Germany) and Austin Hospital (Melbourne, Australia).

The Philips decision support software has shown positive results in retrospective studies using libraries of FDG-PET brain-scan images that had already been independently interpreted by an expert. In a study based on a University Medical Center Hamburg-Eppendorf library of FDG-PET scans from 83 patients, the software achieved better than 98 percent correspondence with the expert physician’s interpretation when programmed to differentiate between brain scans showing no signs of dementia, brain scans characteristic of Alzheimer’s disease and those characteristic of Frontotemporal Dementia.

In a similar 48-patient study using FDG-PET images provided by the Austin Hospital (courtesy of Professor Christopher Rowe, Director of Nuclear Medicine & Centre for PET, Austin Hospital) the software achieved better than 80 percent accuracy in differentiating between the scans of un-diseased patients, those suffering from Alzheimer’s, those suffering from Frontotemporal Dementia and those suffering from Lewy Body Dementia. This so-called 4-class differential diagnosis is more difficult because indications of Alzheimer’s and Lewy Body Dementia occur in similar areas of the brain, while indications of Frontotemporal Dementia appear in a separate area of the brain.

The Philips software analyzes PET brain-scan images and combines them with MRI (Magnetic Resonance Imaging) scans to detect the characteristic patterns of brain diseases such as Alzheimer’s, Frontotemporal Dementia and Lewy Body Dementia. It then quantifies the degree to which they resemble reference images of known dementia sufferers. The University Medical Center Hamburg-Eppendorf - codeveloper of the system - has been using the software alongside its existing diagnostic procedures for the last year to evaluate its feasibility and usability in a clinical setting.

“Computer-based clinical decision support is regarded as one of the best ways of enabling physicians to optimally use available data and knowledge so that they can consistently deliver evidence-based medicine to their patients in a timely manner,” says Dr. Henk van Houten, senior vice president Philips Research and head of the Healthcare research program. “Ultimately, such systems will be judged by the people who use them, and that is why it is important to develop this decision support software to aid the diagnosis of dementia in close collaboration with leading dementia research institutes.”

Following on from the encouraging results of these studies, Philips Research is conducting additional studies involving the software in collaboration with the University of Washington (Seattle, USA).

For more information: www.medical.philips.com

Related Content

Lucence Diagnostics to Develop AI Tools for Liver Cancer Treatment

Pseudocolor accentuated CT scan image of a liver tumor. Image courtesy of Lucence Diagnostics.

News | Oncology Diagnostics | March 12, 2019
Genomic medicine company Lucence Diagnostics announced a new project to develop artificial intelligence (AI) algorithms...
Amazon Comprehend Medical Brings Medical Language Processing to Healthcare
News | Artificial Intelligence | February 15, 2019
Amazon recently announced Amazon Comprehend Medical, a new HIPAA-eligible machine learning service that allows...
Siemens Healthineers Demonstrates Artificial Intelligence, Healthcare Digitalization at HIMSS19
News | Artificial Intelligence | February 13, 2019
February 13, 2019 — At the 2019 Healthcare Information and Management Systems Society (HIMSS) global conference and e
New Appropriate Use Criteria Outlined for Multimodality Imaging of Nonvalvular Heart Disease
News | Cardiac Imaging | February 11, 2019
The American College of Cardiology (ACC), along with nine other cardiology professional societies, recently published a...
IMS to Unveil Prototype Imaging Machine Learning Platform at HIMSS19
News | Artificial Intelligence | February 06, 2019
International Medical Solutions (IMS) announced a solution that will enable radiologists and other clinicians to use...
Siemens Healthineers Syngo.Breast Care Adding AI-Based Decision Support
News | Clinical Decision Support | February 05, 2019
Siemens Healthineers showcased the new planned artificial intelligence (AI)-based features with its mammography reading...
Infinitt Showcases New RIS/PACS Features at RSNA 2018
News | PACS | December 19, 2018
Infinitt North America highlighted a range of healthcare information technology (IT) products and applications at the...
ScreenPoint Medical and Volpara Partner to Bring AI to Breast Imaging Clinics
News | Computer-Aided Detection Software | December 04, 2018
ScreenPoint Medical has signed a memorandum of understanding (MOU) with Volpara Health Technologies. Volpara will...
ScreenPoint Medical Receives FDA Clearance for Transpara Mammography AI Solution
Technology | Computer-Aided Detection Software | November 28, 2018
November 28, 2018 — ScreenPoint Medical announced it has received 510(k) clearance from the U.S.
Volpara Solutions Showcases Latest VolparaEnterprise Software Tools at RSNA
News | Mammography | November 21, 2018
Volpara Solutions Inc. will showcase its latest artificial intelligence (AI) updates at the 104th Annual Radiological...